Efficacy of Indacaterol 150 µg Versus Formoterol

NCT01377428 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Indacaterol
DRUG: Formoterol

Sponsor

Novartis Pharmaceuticals